Trulicity Best For: Patients who prefer once-weekly convenience over daily dosing, those with established cardiovascular disease or multiple cardiovascular risk factors seeking FDA-approved cardiovascular risk reduction, patients with adherence challenges who benefit from less frequent dosing, and pediatric patients aged 10 years and older
Anal Chim Acta 1027:121129
Radiographic midfacial volume changes in patients on GLP-1 agonists
Until, and if, it returns to shelves, have a read of this blog to learn about the current data on its benefits to see how it may help with longevity
Sources : Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial (2024) Nature Medicine [Accessed 11 November 2025] Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes | New England Journal of Medicine [Accessed 11 November 2025] Clinical Review - Semaglutide (Wegovy) NCBI Bookshelf [Accessed 11 November 2025] How to Use the Wegovy Pen | Wegovy (semaglutide) Injection 2.4 mg (2025) Novo Nordisk [Accessed 11 November 2025] Tirzepatide Once Weekly for the Treatment of Obesity (2022) New England Journal of Medicine [Accessed 11 November 2025] Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial (2022) Nature Medicine [Accessed 11 November 2025] Wegovy - Uses, How it Works and Side Effects (2025) Diabetes UK [Accessed 11 November 2025] Its natural to have questions, and were here to keep things straightforward so you can stay focused on your journey
Side effects may include nausea or constipation
